Αποτελέσματα Αναζήτησης
1 Ιαν 2023 · IR of major amputations was 94.82 (95% CI 56.62–158.80) per 100,000 individuals with diabetes, among patients with type 1 diabetes was 100.76 (95% CI 53.71–189.01) and among type 2 diabetes was 40.58 (95% CI 11.03–149.28).
- Gender Differences in Risk Factors for Coronary Heart Disease
1.. IntroductionCoronary heart disease (CHD) is the leading...
- Peripheral Neuropathy in Patients With Diabetic Foot Ulcers
Diabetes mellitus (DM) leads to complications in every organ...
- Gender Differences in Risk Factors for Coronary Heart Disease
25 Ιουν 2020 · The burden of amputation is severe, with 5-year mortality rates exceeding those of many malignancies. Furthermore, caring for patients with PAD and diabetes mellitus imposes a significant cost to the healthcare system—estimated to range from $84 billion to $380 billion annually.
Statistics reveal that 25% of the hospital admissions among diabetics are for the foot lesions and of those presenting with diabetic foot, 40% require amputations [2]. 50-70% of all non traumatic amputations occur in diabetics [3]. The management includes control of diabetes, infections and assessment of the vascular status.
28 Αυγ 2017 · Lower extremity amputation (LEA) in patients with diabetes results in high mortality, reduced quality of life, and increased medical costs.
The incidence of lower extremity reamputation is high among patients with diabetes who have undergone initial amputations secondary to diabetes, and rates of reamputation have not changed over at least two decades.
IR estimates of diabetes-related amputations with associated 95% confidence interval (CI) per 100,000 individuals with diabetes were calculated. Results: 23 studies were included, reporting 505,390 diabetes-related lower extremity amputations. IR of minor amputations was 139.97 (95% CI 88.18-222.16) per 100,000 individuals with diabetes, among ...
Prevalence of concurrent peripheral arterial disease and diabetes is increasing, but amputation rates and amputation-free survival vary significantly by both race and hospital referral region. Prevention and care coordination effort should aim to limit racial disparities in the treatment and outcomes of these high-risk patients.
